However, subsequent studies revealed that higher frequencies of intraepithelial CD8+ T cells, expressing the αE integrin subunit CD103, are associated with a better survival prognosis in ovarian cancer, suggesting that CD8+ T cells rather than CD4+ lymphocytes contribute to the antitumor effects (149–151). The gene discussed is CD8A; the disease is ovarian cancer.